Molecular cytogenetic evaluation of 10 uveal melanoma cell lines

Cancer Genetics and Cytogenetics

Volumn 168, Issue 1, 2006, Pages 11-21

  White, Jason S ^a,b   Becker, Robert L ^b   McLean, Ian W ^b   Director Myska, Alison E ^b,c   Nath, Joginder ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; CENTROMERE; CHROMOSOME 3; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; KARYOTYPING; MONOSOMY; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; TELOMERE; UVEA MELANOMA;

CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MELANOMA; NUCLEIC ACID HYBRIDIZATION; UVEAL NEOPLASMS;

EID: 33744937102     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.11.016     Document Type: Article

References (48)

1. Singh A.D., and Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 110 (2003) 956-961
2. Gordon K.B., Thompson C.T., Char D.H., O'Brien J.M., Kroll S., Ghazvini S., and Gray J.W. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res 54 (1994) 4764-4768
3. McLean I.W., and Gamel J.W. Uveal (intraocular) melanoma. Cancer J 9 (1996) 20-25
4. Prescher G., Bornfeld N., Hirche H., Horsthemke B., Jockel K.H., and Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347 (1996) 1222-1225
5. Kincaid M.C. Uveal melanoma. Cancer Control 5 (1998) 299-309
6. Sun Y., Tran B.N., Worley L.A., Delston R.B., and Harbour J.W. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. Invest Ophthalmol Vis Sci 46 (2005) 1561-1564
7. Regan S., Judge H.E., Gragoudas E.S., and Egan K.M. Iris color as a prognostic factor in ocular melanoma. Arch Ophthalmol 117 (1999) 811-814
8. Harbour J.W., Brantley Jr. M.A., Hollingsworth H., and Gordon M. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br J Ophthalmol 88 (2004) 39-43
9. Tucker M.A., Shields J.A., Hartge P., Augsburger J., Hoover R.N., and Fraumeni Jr. J.F. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 313 (1985) 789-792
10. Egan K.M., Seddon J.M., Glynn R.J., Gragoudas E.S., and Albert D.M. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32 (1988) 239-251
11. Holly E.A., Aston D.A., Char D.H., Kristiansen J.J., and Ahn D.K. Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 50 (1990) 5773-5777
12. Dolin P.J., Foss A.J., and Hungerford J.L. Uveal melanoma: is solar ultraviolet radiation a risk factor?. Ophthalmic Epidemiol 1 (1994) 27-30
13. Pane A.R., and Hirst L.W. Ultraviolet light exposure as a risk factor for ocular melanoma in Queensland, Australia. Ophthalmic Epidemiol 7 (2000) 159-167
14. Hu D.N. Photobiology of ocular melanocytes and melanoma. Photochem Photobiol 81 (2005) 506-509
15. Coupland S.E., Anastassiou G., Stang A., Schilling H., Anagnostopoulos I., Bornfeld N., and Stein H. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma. J Pathol 191 (2000) 120-126
16. Honda S., Hirai T., Handa J.T., Okuno T., and Saito I. Expression of cell cycle related proteins in a rapidly growing uveal malignant melanoma. Retina 24 (2004) 646-649
17. Singh A.D., Wang M.X., Donoso L.A., Shields C.L., De Potter P., and Shields J.A. Genetic aspects of uveal melanoma: a brief review. Semin Oncol 23 (1996) 768-772
18. Speicher M.R., Prescher G., du Manoir S., Jauch A., Horsthemke B., Bornfeld N., Becher R., and Cremer T. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 54 (1994) 3817-3823
19. Ghazvini S., Char D.H., Kroll S., Waldman F.M., and Pinkel D. Comparative genomic hybridization analysis of archival formalin-fixed paraffin-embedded uveal melanomas. Cancer Genet Cytogenet 90 (1996) 95-101
20. Aalto Y., Eriksson L., Seregard S., Larsson O., and Knuutila S. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 42 (2001) 313-317
21. White V.A., McNeil B.K., and Horsman D.E. Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma. Cancer Genet Cytogenet 102 (1998) 40-45
22. Sisley K., Rennie I.G., Parsons M.A., Jacques R., Hammond D.W., Bell S.M., Potter A.M., and Rees R.C. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 19 (1997) 22-28
23. White V.A., Chambers J.D., Courtright P.D., Chang W.Y., and Horsman D.E. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83 (1998) 354-359
24. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., and Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 (1992) 818-821
25. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., and Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
26. Schröck E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., and Ried T. Multicolor spectral karyotyping of human chromosomes. Science 273 (1996) 494-497
27. Macville M., Veldman T., Padilla-Nash H., Wangsa D., O'Brien P., Schröck E., and Ried T. Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements. Histochem Cell Biol 108 (1997) 299-305
28. Naus N.C., van Drunen E., de Klein A., Luyten G.P., Paridaens D.A., Alers J.C., Ksander B.R., Beverloo H.B., and Slater R.M. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Genes Chromosomes Cancer 30 (2001) 267-273
29. McNamara M., Felix C., Davison E.V., Fenton M., and Kennedy S.M. Assessment of chromosome 3 copy number in ocular melanoma using fluorescence in situ hybridization. Cancer Genet Cytogenet 98 (1997) 4-8
30. Parrella P., Sidransky D., and Merbs S.L. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res 59 (1999) 3032-3037
31. Sandinha M.T., Farquharson M.A., and Roberts F. Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation. Br J Ophthalmol 88 (2004) 1527-1532
32. White V.A., McNeil B.K., Thiberville L., and Horsman D.E. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity. Genes Chromosomes Cancer 15 (1996) 138-143
33. Sisley K., Curtis D., Rennie I.G., and Rees R.C. Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma. Melanoma Res 3 (1993) 457-461
34. Blasi M.A., Roccella F., Balestrazzi E., Del Porto G., De Felice N., Roccella M., Rota R., and Grammatico P. 3p13 region: a possible location of a tumor suppressor gene involved in uveal melanoma. Cancer Genet Cytogenet 108 (1999) 81-83
35. Myatt N., Aristodemou P., Neale M.H., Foss A.J., Hungerford J.L., Bhattacharya S., and Cree I.A. Abnormalities of the transforming growth factor-beta pathway in ocular melanoma. J Pathol 192 (2000) 511-518
36. Tschentscher F., Prescher G., Zeschnigk M., Horsthemke B., and Lohmann D.R. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 122 (2000) 13-17
37. Tschentscher F., Prescher G., Horsman D.E., White V.A., Rieder H., Anastassiou G., Schilling H., Bornfeld N., Bartz-Schmidt K.U., Horsthemke B., Lohmann D.R., and Zeschnigk M. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res 61 (2001) 3439-3442
38. Tschentscher F., Husing J., Holter T., Kruse E., Dresen I.G., Jockel K.H., Anastassiou G., Schilling H., Bornfeld N., Horsthemke B., Lohmann D.R., and Zeschnigk M. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 63 (2003) 2578-2584
39. Scholes A.G., Liloglou T., Maloney P., Hagan S., Nunn J., Hiscott P., Damato B.E., Grierson I., and Field J.K. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Invest Ophthalmol Vis Sci 42 (2001) 2472-2477
40. Scholes A.G., Damato B.E., Nunn J., Hiscott P., Grierson I., and Field J.K. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 44 (2003) 1008-1011
41. Parrella P., Fazio V.M., Gallo A.P., Sidransky D., and Merbs S.L. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res 63 (2003) 8507-8510
42. Cross NA, Ganesh A, Parpia M, Murray AK, Rennie IG, Sisley K. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye 2006;20:476-81.
43. De Waard-Siebinga I., Blom D.J., Griffioen M., Schrier P.I., Hoogendoorn E., Beverstock G., Danen E.H., and Jager M.J. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 62 (1995) 155-161
44. Chen P.W., Murray T.G., Uno T., Salgaller M.L., Reddy R., and Ksander B.R. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. Clin Exp Metastasis 15 (1997) 509-518
45. Kan-Mitchell J., Mitchell M.S., Rao N., and Liggett P.E. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci 30 (1989) 829-834
46. Albert D.M., Ruzzo M.A., McLaughlin M.A., Robinson N.L., Craft J.L., and Epstein J. Establishment of cell lines of uveal melanoma: methodology and characteristics. Invest Ophthalmol Vis Sci 25 (1984) 1284-1299
47. Luyten G.P., Naus N.C., Mooy C.M., Hagemeijer A., Kan-Mitchell J., van Drunen E., Vuzevski V., de Jong P.T., and Luider T.M. Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int J Cancer 66 (1996) 380-387
48. ISCN 1995: an international system for human cytogenetic nomenclature (1995). In: Mitelman F. (Ed) (1995), S. Karger, Basel